DUBLIN (AP) _ Jazz Pharmaceuticals PLC (JAZZ) on Tuesday reported first-quarter earnings of $85.2 million.
The Dublin-based company said it had net income of $1.47 per share. Earnings, adjusted for one-time gains and costs, were $3.67 per share.
The results topped Wall Street expectations. The average estimate of 11 analysts surveyed by Zacks Investment Research was for earnings of $3.16 per share.
The drugmaker posted revenue of $508.2 million in the period, also topping Street forecasts. Eight analysts surveyed by Zacks expected $471 million.
Jazz expects full-year earnings in the range of $14.30 to $15 per share, with revenue in the range of $2.05 billion to $2.13 billion.
Jazz shares have climbed nearly 4% since the beginning of the year. In the final minutes of trading on Tuesday, shares hit $128.65, a decrease of 13% in the last 12 months.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on JAZZ at https://www.zacks.com/ap/JAZZ